Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

OBJECTIVE: To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: de Moel, Emma C., Rech, Jürgen, Mahler, Michael, Roth, Johannes, Vogl, Thomas, Schouffoer, Anne, Goekoop, Robbert J., Huizinga, Tom W. J., Allaart, Cornelia F., Toes, René E. M., Schett, Georg, van der Woude, Diane
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894482/
https://ncbi.nlm.nih.gov/pubmed/31805992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-2064-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados